China National Medicines Corporation Ltd. (SHA:600511)

Market Cap	19.92B -11.5%
Revenue (ttm)	53.56B +4.1%
Net Income	1.93B -1.0%
EPS	2.55 -1.0%
Shares Out	754.50M
PE Ratio	10.33
Forward PE	9.50
Dividend	0.80 (2.95%)
Ex-Dividend Date	Jun 18, 2026

Volume	5,195,106
Open	26.73
Previous Close	26.84
Day's Range	26.23 - 26.73
52-Week Range	25.11 - 31.18
Beta	0.14
Analysts	Strong Buy
Price Target	36.43 (+37.99%)
Earnings Date	Aug 20, 2026

About SHA:600511

China National Medicines Corporation Ltd., together with its subsidiaries, engages in pharmaceutical equipment circulation in China. The company also manufactures and sells new drugs; sells Chinese patent medicines drug sales and western medicines, and medical equipment; and offers dental drug and equipment, warehousing, logistics and import and export agency services. It also serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China. China National Medicines Corporation Ltd. o...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1999
• Employees: 3,024
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2025, SHA:600511's revenue was 52.47 billion, an increase of 3.70% compared to the previous year's 50.60 billion. Earnings were 2.00 billion, a decrease of -0.18%.

Analyst Summary

According to 2 analysts, the average rating for 600511 stock is "Strong Buy." The 12-month stock price target is ¥36.43, which is an increase of 37.99% from the latest price.

Price Target

¥36.43

(37.99% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 21, 2026

Data Sources Report a data error